Setmelanotide Acetate Patent Expiration
Setmelanotide Acetate was first introduced by Rhythm Pharmaceuticals Inc
Setmelanotide Acetate Patents
Given below is the list of patents protecting Setmelanotide Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Imcivree | US11129869 | Pharmaceutical compositions | Jul 04, 2034 | Rhythm |
| Imcivree | US8039435 | Melanocortin receptor ligands | Oct 13, 2027 | Rhythm |
| Imcivree | US9458195 | Melanocortin receptor ligands | Oct 13, 2027 | Rhythm |
Setmelanotide Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List